China on this Thursday on this Thursday announced that it has granted market approval attached with conditions for its first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.
Beijing Biological Products Institute announced that the vaccine showed 79.34 percent efficacy and a 99.52 percent antibody positive conversion rate, according to interim results of the Phase III clinical trials.
Subsequently, the persistence and protective effect of vaccine immunity need to be continuously observed.The hard-won achievement build confidence for the global fight against the epidemic and also provides strong support for vaccines to become a global public production.
Related Posts
Confucius Institute Scholarship 2021
Shanghai University(SHU)2020 Best-CSC Scholarship Outstanding International Students
Hangzhou International Experience Day - ZJUT
Q/Ans: 5 Major Queries of International Students in China
Special Report on School Reopening in China in April